Clinical Trial Update: A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir [Phase 3]

View source ↗

Summary

A multicenter Phase 3 trial evaluating second-line antiretroviral regimens with atazanavir or lopinavir/ritonavir in African adults has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ATAZANAVIR (atazanavir)
• Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV | Phase 3 | Status: WITHDRAWN